A new clinical practice guideline has been released, but the specific focus of the guideline is unclear, with reports suggesting it may pertain to androgen excess in women, central precocious puberty, menopause and perimenopause management, or other endocrine-related topics. Some outlets indicate the guideline is an update, while others suggest it is the first of its kind. The guideline appears to be related to endocrinology, but its exact scope and application are not consistently reported.